Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes
Martin, Karlyn¹; Kia, Leila¹; Parikh, Nehar D²; Kulik, Laura¹; McMahon, Brandon^1
1Northwestern University Feinberg, School of Medicine, Chicago, Illinois. Estados Unidos de América; ²University of Michigan, Department of Medicine, Ann Arbor, Michigan. Estados Unidos de América
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 548-554]

Hepatitis E virus exposure in pregnant women in rural Durango, Mexico
Alvarado Esquivel, Cosme¹; Sánchez Anguiano, Luis F²; Hernández Tinoco, Jesús^2
1Universidad Juárez del Estado de Durango, Facultad de Medicina y Nutrición, Durango. México; ²Universidad Juárez del Estado de Durango, Instituto de Investigación Científica, Durango. México
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 510-517]

Hupffer cells: increasingly significant role in nonalcoholic fatty liver disease
Zhang Wenfeng¹; Wu Yakun¹; Mu Di¹; Gong Jianping¹; Wu Chuanxin¹; Huang Chun^1
1Chongqing Medical University, Second Affiliated Hospital, Chongquing, Sichuan. China
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 489-495]

Juvenile hemochromatosis associated with heterozygosity for novel hemojuvelin mutations and with unknown cofactors
Pelusi, Serena¹; Rametta, Raffaela¹; Corte, Claudia Della²; Congia, Riccardo²; Dongiovanni, Paola¹; Pulixi, Edoardo A¹; Fargion, Silvia¹; Fracanzani, Anna L¹; Nobili, Valerio²; Valenti, Luca^1
1Universita degli Studi di Milano, Department of Pathophysiology and Transplantation, Milán, Lombardia. Italia; ²Ospedale Pediatrico Bambino Gesu, Hepato-Metabolic Unit, Roma, Lazio. Italia
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 568-571]

Mean platelet volume: a useful predictor of ascitic fluid infection in cirrhotic patients?
Tanoglu, Alpaslan¹; Karagoz, Ergenekon^2
1GATA Haydarpasa Training Hospital, Department of Gastroenterology, Estambul. Turquía; ²GATA Haydarpasa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Estambul. Turquía
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 572]

Mean platelet volume is a useful indicator of systemic inflammation in cirrhotic patients with ascitic fluid infection
Suvak, Burak¹; Torun, Serkan¹; Tas, Adnan¹; Beyazit, Yavuz^1
1Turkiye Yuksek Yhtisas Training and Research Hospital, Department of Gastroenterology, Ankara. Turquía
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 573]

Minimally invasive treatment of Mirizzi’s syndrome: is there a safe way? Report of a case series
Piccinni, Giuseppe¹; Sciusco, Andrea¹; Luca, Giuseppe Massimiliano de¹; Gurrado, Angela¹; Pasculli, Alessandro¹; Testini, Mario^1
1Universita degli Studi di Bari Aldo Moro, Bari, Puglia. Italia
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 558-564]

Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients
Buss, Caroline¹; Valle-Tovo, Cristiane¹; Miozzo, Suellen¹; Alves de Mattos, Angelo^1
1Universidade Federal de Ciencias da Saude de Porto Alegre, Porto Alegre, Rio Grande do Sul. Brasil
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 482-488]

Promotor methylation: Does it affect response to therapy in chronic hepatitis C (G4) or fibrosis?
Zekri, Abdel-Rahman N¹; Raafat, Ahmed M¹; Elmasry, Suzan²; Bahnassy, Abeer A¹; Saad, Yasmin³; Dabaon, Hamed A²; El-Kassas, Mohamed³; Shousha, Hend I³; Nassar, Auhood A¹; EL-Dosouky, Mohamed Ale²; Hussein, Nehal^1
1National Cancer Institute, Cancer Biology Department, El Cairo. Egipto; ²Cairo University, Faculty of Science, El Cairo. Egipto; ³Cairo University, Faculty of Medicine, El Cairo. Egipto
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 518-524]

Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience
Faisal, Nabiha¹; Yoshida, Eric M²; Bilodeau, Marc³; Wong, Philip⁴; Ma, Mang⁵; Burak, Kelly W⁶; Al-Judaibi, Bandar⁷; Renner, Eberhard L¹; Lilly, Leslie B^1
1University of Toronto, Toronto General Hospital, Toronto, Ontario. Canadá; ²University of British Columbia, Vancouver, Columbia Británica. Canadá; ³Montreal University, Quebec. Canadá; ⁴McGill University, Quebec. Canadá; ⁵University of Alberta, Edmonton, Alberta. Canadá; ⁶University of Calgary, Calgary, Alberta. Canadá; ⁷Western University, London, Ontario. Canadá
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 525-532]

Survey of health status, nutrition and geography of food selection of chronic liver disease patients
Leslie, Timothy¹; Pawloski, Lisa¹; Kallman-Price, Jillian¹; Escheik, Carey¹; Hossain, Noreen¹; Fang, Yun¹; Gerber, Lynn H¹; Younossi, Zobair M^1
1Betty and Guy Beatty Center for Integrated Research, Falls Church, Virginia. Estados Unidos de América
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 533-540]

The good, the bad and the ugly of the new treatments for hepatitis C virus
Karen V Silva-Vidal¹; Méndez Sánchez, Nahum^1
1Fundación Clínica Médica Sur, Liver Research Unit, México, Distrito Federal. México
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 574-575]

Treatment of chronic hepatitis C genotype 1 early responders with 36 week pegylated interferon and ribavirin therapy
Sood, Ajit¹; Midha, Vandana¹; Goyal, Omesh^1
1Dayanand Medical College, Punjab, Haryana. India
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 503-509]

Ultra-sensitive procalcitonin may help rule out bacterial infections in patients with cirrhosis
Marciano, Sebastián¹; Haddad, Leila¹; Martínez, Alfredo P²; Posadas, María L³; Piñero, Federico¹; Mora, Gonzalo J¹; Guerrero, Laura N²; Ridruejo, Ezequiel¹; Mandó, Oscar G¹; Giunta, Diego H³; Gadano, Adrián C^1
1Hospital Italiano de Buenos Aires, Unidad de Hígado, Buenos Aires. Argentina; ²Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno", Buenos Aires. Argentina; ³Hospital Italiano de Buenos Aires, Unidad de Investigación en Medicina Interna, Buenos Aires. Argentina
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 541-547]

Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina
Munné, María S¹; Altabert, Nancy R¹; Otegui, Lucio O¹; Vladimirsky, Sara N¹; Moreiro, Rita²; Espul, María P³; Espul, Carlos Espul⁴; Manzur, Abelardo⁴; Soto, Sonia S¹; Brajterman, Leonardo S¹; González, Jorge E^1
1Instituto Nacional de Enfermedades Infecciosas, Laboratorio Nacional de Referencia de Hepatitis Virales, Buenos Aires. Argentina; ²Hospital Pediátrico J.P. Garrahan, Buenos Aires. Argentina; ³Universidad Juan Agustín Maza, Facultad de Ciencias Veterinarias, Mendoza. Argentina; ⁴Hospital Central, División de Virología, Mendoza. Argentina
[Annals of hepatology, México, 2014 Vol. 13 Núm. 5 Sep-Oct, Pág. 496-502]

Adult human liver contains intermediate-type proteasomes with different enzymatic properties
Gohlke, Sabrina¹; Klob, Alexander¹; Tsokos, Michael²; Textoris-Taube, Kathrin¹; Keller, Christin¹; Kloetzel, Peter-Michael¹; Dahlmann, Burkhardt^1
1Charite Universitatsmedizin Berlin, Institut fur Biochemie, Berlín. Alemania; ²Charite Universitatsmedizin Berlin, Institut fur Rechtsmedizin, Berlín. Alemania
[Annals of hepatology, México, 2014 Vol. 13 Núm. 4 Jul-Ago, Pág. 429-438]

A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV
Rodriguez Torres, Maribel¹; Yoshida, Eric M²; Marcellin, Patrick³; Srinivasan, Subasree⁴; Purohit, Vivek S⁴; Wang, Cunshan⁴; Hammond, Jennifer L^4
1Escuela de Medicina San Juan Bautista, San Juan. Puerto Rico; ²University of British Columbia, Vancouver, Columbia Británica. Canadá; ³Universite Paris Diderot, Clichy, París. Francia; ⁴Pfizer Laboratories, Global Innovative Pharma Business Unit, Groton, Connecticut. Estados Unidos de América
[Annals of hepatology, México, 2014 Vol. 13 Núm. 4 Jul-Ago, Pág. 364-375]

Deep sequencing analysis of microRNA expression in porcine serum-induced hepatic fibrosis rats
Ge, Shanfei¹; Wang, Xiaowei²; Xie, Jianping¹; Xin Yi³; Liu, Fei^1
1Central South University, Xiangya Hospital, Changsha, Hunan. China; ²BGI-tianjin, Tianjin. China; ³Beijing Genomics Institute, Bioinformatics Center, Shenzhen. China
[Annals of hepatology, México, 2014 Vol. 13 Núm. 4 Jul-Ago, Pág. 439-449]

Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort
Paranagua-Vezozzo, Denise C¹; Ono, Suzane K¹; Alvarado-Mora, Mónica V¹; Farias, Alberto Q¹; Cunha-Silva, Marlone²; Franca, Joao I.D²; Alves, Venancio A.F¹; Sherman, Morris³; Carrilho, Flair Jose^1
1Universidade de Sao Paulo, Hospital de Clinicas, Sao Paulo. Brasil; ²Universidade de Sao Paulo, Faculdade de Medicina, Sao Paulo. Brasil; ³University of Toronto, Department of Gastroenterology, Toronto, Ontario. Canadá
[Annals of hepatology, México, 2014 Vol. 13 Núm. 4 Jul-Ago, Pág. 386-393]

Hemodynamic effect of carvedilol vs. propranolol in cirrhotic patients: Systematic review and meta-analysis
Aguilar Olivos, Nancy¹; Motola Kuba, Miguel¹; Candia, Roberto²; Arrese, Marco²; Méndez Sánchez, Nahum¹; Uribe, Misael¹; Chávez Tapia, Norberto C^1
1Fundación Clínica Médica Sur, México, Distrito Federal. México; ²Pontificia Universidad Católica de Chile, Facultad de Medicina, Santiago de Chile. Chile
[Annals of hepatology, México, 2014 Vol. 13 Núm. 4 Jul-Ago, Pág. 420-428]